Iovance Biotherapeutics, Inc.
2020 Q2 - 2025 Q4 (14 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 768 | 0.0% | 281,477 | 12/31/2025 |
| 2025 Q1 | 5/14/2025 | 3,899 | 0.1% | 1,170,745 | 3/31/2025 |
| 2023 Q3 | 11/13/2023 | 449 | 0.0% | 98,663 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 3,167 | 0.0% | 449,900 | 6/30/2023 |
| 2022 Q4 | 2/13/2023 | 1,621 | 0.0% | 253,733 | 12/31/2022 |
| 2022 Q3 | 11/10/2022 | 674 | 0.0% | 70,379 | 9/30/2022 |
| 2022 Q2 | 8/22/2022 | 1,102 | 0.0% | 99,779 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 2,304 | 0.0% | 138,355 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 295 | 0.0% | 15,479 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 734 | 0.0% | 29,754 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 1,370 | 0.0% | 52,652 | 6/30/2021 |
| 2020 Q4 | 2/16/2021 | 2,119 | 0.0% | 45,671 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 500 | 0.0% | 15,176 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 2,386 | 0.1% | 86,920 | 6/30/2020 |